The to tal decrease rate of migraine attacks (%) of therapeutic group and placebo group were .9±0. and .0±0.(Z=.7,P<0.00), respectively. It has marked statist ical difference (P<0.00).
The to tal decrease rate of migraine attacks (%) of therapeutic group and placebo group were .9±0. and .0±0.(Z=.7,P<0.00), respectively. It has marked statist ical difference (P<0.00).
治疗组和安慰剂组总发作次数减少率 ( % )分别为 9± 0 和 0± 0 ,两组比较差异有显著意义 (Z = 7,P <0 0 0 )。